The Group's principal activities are to develop, manufacture and sell a complete line of reagents and automated systems that detect and identify certain properties of the cell and serum components of human blood for the purpose of blood transfusion. Its offerings are targeted at hospitals, donor centers and clinical laboratories. It offers customers a selection of automated analyzers, marketed as Scalable Solutions, which address the various needs of low, medium, and high-volume testing facilities. The Group operates in Belgium, France, Germany, Italy, Portugal, Spain and the United Kingdom.
Alacra Alerts:
Receive alerts on the latest reports on Immucor, Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
